Skip to content

Optimizing Study on Maintenance Intervals for Implantable Port Patients During Non-Treatment Periods

Optimizing Study on Maintenance Intervals for Implantable Port Patients During Non-Treatment Periods

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109149
Enrollment
Unknown
Registered
2025-09-12
Start date
2025-07-04
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications of implantable venous ports

Interventions

Maintain the group every 8 weeks:Extend maintenance period to 8 weeks
The group is maintained every 12 weeks.:Extend maintenance period to 12 weeks
Maintain the group once every four weeks.:Maintain once every four weeks

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The patient's age is between 18 and 80 years old. (2) The patient has been diagnosed with a malignant tumor and has undergone the implantation of an infusion port. (3) The patient is in a convalescence period and will no longer use the infusion port for chemotherapy within one year. (4) The patient is expected to survive for more than half a year. (5) The implanted infusion port is a single-chamber port on the chest wall. (6) The patient has signed the informed consent form for participating in the clinical trial and is willing to be followed up.

Exclusion criteria

Exclusion criteria: (1) Patients with hematological malignancies (leukemia, lymphoma, multiple myeloma); (2) Patients with chronic kidney diseases (nephrotic syndrome, diabetic kidney disease, lupus nephritis); (3) BMI = 28 kg/m²; (4) Had a history of arterial-venous thrombosis within 1 year; (5) Had complications of infusion port: infection, intravenous thrombosis, catheter blockage, catheter tip displacement, catheter rupture or injury, drug extravasation. ; (6) There are patients with chronic cough and vomiting; (7) There are cases where the patients have cognitive dysfunction or mental disorders and are unable to understand the research process.

Design outcomes

Primary

MeasureTime frame
infection;Catheter blockage;Inverted infusion port injection seat;thrombus;Displacement of catheter tip;Catheter rupture or breakage;Medication extravasation;

Secondary

MeasureTime frame
Medical expenses;Patient satisfaction;

Countries

China

Contacts

Public ContactCao Jie

First Affiliated Hospital of Naval Medical University, Nursing Department

celion2004@126.com+86 138 1779 7641

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026